Konferenzpaper

Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management


AutorenlisteBretzel, RG; Brandhorst, D; Brandhorst, H; Eckhard, M; Ernst, W; Freimann, S; Rau, W; Weimar, B; Rauber, K; Hering, BJ; Brendel, MD

Jahr der Veröffentlichung1999

Seiten140-143

ZeitschriftJournal of Molecular Medicine

Bandnummer77

Heftnummer1

ISSN0946-2716

eISSN1432-1440

DOI Linkhttps://doi.org/10.1007/s001090050322

KonferenzInternational Symposium on Endocrine Cell Transplantation and Genetic Engineering

VerlagSpringer



Zitierstile

Harvard-ZitierstilBretzel, R., Brandhorst, D., Brandhorst, H., Eckhard, M., Ernst, W., Freimann, S., et al. (1999) Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management, Journal of Molecular Medicine, 77(1), pp. 140-143. https://doi.org/10.1007/s001090050322

APA-ZitierstilBretzel, R., Brandhorst, D., Brandhorst, H., Eckhard, M., Ernst, W., Freimann, S., Rau, W., Weimar, B., Rauber, K., Hering, B., & Brendel, M. (1999). Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management. Journal of Molecular Medicine. 77(1), 140-143. https://doi.org/10.1007/s001090050322



Schlagwörter


clinical islet transplantationislet isolationTRANSPLANTATIONtype-1 diabetes mellitus


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:31